Key stats
About HSBC MSCI EMERGING MARKETS UCITS ETF USD (ACC)
Home page
Inception date
Sep 5, 2011
Structure
Irish VCIC
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
HSBC Investment Funds (Luxembourg) SA
ISIN
IE000KCS7J59
The Fund aims to track as closely as possible the returns of the MSCI Emerging Markets Index (the Index). The Fund will invest in or gain exposure to shares of companies which make up the Index.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
HEMA assets under management is 418.00 M EUR. It's risen 3.44% over the last month.
HEMA fund flows account for 187.36 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, HEMA doesn't pay dividends to its holders.
HEMA shares are issued by HSBC Holdings Plc under the brand HSBC. The ETF was launched on Sep 5, 2011, and its management style is Passive.
HEMA expense ratio is 0.15% meaning you'd have to pay 0.15% of your investment to help manage the fund.
HEMA follows the MSCI EM (Emerging Markets). ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
HEMA price has fallen by −0.72% over the last month, and its yearly performance shows a 4.93% increase. See more dynamics on HEMA price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −0.89% over the last month, have fallen by −0.89% over the last month, showed a −0.50% decrease in three-month performance and has increased by 5.32% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −0.89% over the last month, have fallen by −0.89% over the last month, showed a −0.50% decrease in three-month performance and has increased by 5.32% in a year.
HEMA trades at a premium (0.08%) meaning the ETF is trading at a higher price than the calculated NAV.